Correspondence regarding: diagnostic utility of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 2009:68;1319-25.
Wiwanitkit
Viroj
V
D014408:Biomarkers, Tumor / Q000235:genetics; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000235:genetics; D003362:Cost-Benefit Analysis; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D005188:False Negative Reactions; D005189:False Positive Reactions; D005404:Fixatives / Q000737:chemistry; D005557:Formaldehyde / Q000737:chemistry; D005819:Genetic Markers; D005910:Glioma / Q000175:diagnosis* / Q000235:genetics; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D010232:Paraffin; D010818:Practice Patterns, Physicians'; D011237:Predictive Value of Tests; D013997:Time Factors; D016610:Tissue Embedding; D016707:Tissue Fixation
D014408:Biomarkers, Tumor; D005404:Fixatives; D005819:Genetic Markers; D005557:Formaldehyde; D010232:Paraffin; D007521:Isocitrate Dehydrogenase; C543588:IDH1 protein, human